Immunocore Holdings PLC reports results for the quarter ended in June - Earnings Summary

Immunocore Holdings

10/08/2022 13:34

* Immunocore Holdings PLC  IMCR.OQ  reported a quarterly
adjusted
loss of 14 pence​​ per share for the quarter ended in June. The
mean expectation of six analysts for the quarter was for a loss
of 67 pence per share.
    * Revenue rose 465% to £32.00 million from a year ago;
analysts
expected £16.03 million. 
    * Immunocore Holdings PLC's reported EPS for the quarter was
a
loss of 14 pence​.
    * The mean earnings estimate of analysts had risen by
about 18.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Immunocore Holdings PLC shares had risen by 38.7% this
quarter and gained 51.1% so far this year.
    * The company reported a quarterly loss of £6.12 million.
    * Wall Street's median 12-month price target for Immunocore
Holdings PLC is $56.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 10
at 12:34 p.m.  ​All figures in pounds unless otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.67          -0.14          Beat
 Mar. 31 2022      -0.84          -0.37          Beat
 Dec. 31 2021      -0.82          -0.91          Missed
 Sep. 30 2021      -0.63          -0.68          Missed